The West is trying to dominate the premium vaccine market

World Vaccine Congress named the best drug for COVID-19 vaccinations

The vaccine from the American company Moderna received an award for its innovativeness, but this solution raises a lot of questions, experts say. So why is the vaccine reported as having side effects as the most advanced vaccine?

“There is a struggle for ownership of the vaccine markets. The political component is understandable given the current state of international relations. Therefore, the awarding of the championship should be considered primarily from this point, and not from the point of view of the quality of the vaccine”, – said Professor Alexander Butenko, head of the laboratory of biology and indication of arboviruses, Research Institute of Virology. Ivanovsky. In his opinion, there are questions about the purity of collegial voting at the congress.

The decision of the World Vaccine Congress is primarily seen as a corporate interest, believes Gleb Kuznetsov, political scientist, head of the expert council of the Expert Institute for Social Research (EISI). “With the help of such PR, Moderna investors are trying to inflate the price of their shares even more,” the source said. – This is an example of absolutely non-market methods of competition that American companies use against European ones, which, among other things, includes our Sputnik V vaccine.

The plans of American investors are to crush the entire premium market for themselves, Kuznetsov believes.

“Therefore, they want to show that RNA vaccines, including Moderna, are for rich and decent people, and for everyone else – the poor, third world countries, Africa, Latin America, India – vector vaccines. Games with mortality are also a competitive tool for vaccine manufacturers”, – the expert noted.